Newcleo to List on Nasdaq via SPAC Merger

Italian advanced nuclear energy innovator newcleo is set to make its public market debut on the Nasdaq through a business combination with NewHold Investment Corp III, a special purpose acquisition company. This strategic move aims to propel the company's ambitious plans for developing fourth-generation nuclear reactors, which uniquely utilize nuclear waste as fuel. The transaction values newcleo at a substantial pre-money equity valuation of approximately $2.4 billion.

The proposed merger is expected to inject significant capital into newcleo, with projections indicating gross proceeds of around $429 million. This figure comprises $220 million from a private investment in public equity (PIPE) round, which saw strong investor interest and oversubscription, alongside up to $209 million in cash from NewHold Investment Corp III's trust account. The net proceeds, estimated at $374 million, are earmarked for fueling the company's organic growth initiatives and further research and development.

The PIPE financing attracted a notable roster of investors, underscoring confidence in newcleo's disruptive technology. Key participants include Exor Ventures, the investment arm of the Agnelli-Elkann family, alongside established entities such as Azimut, Walter Tosto, the CERN Pension Fund, and the Milan-listed industrial giant Danieli. This broad support from both financial and strategic investors highlights the perceived potential of newcleo's approach to nuclear energy.

Founded in 2021 by Stefano Buono, a CERN alumnus with a successful track record including the sale of Advanced Accelerator Applications to Novartis for $3.9 billion, newcleo has already secured substantial backing. Prior to this SPAC transaction, the company had raised approximately $780 million from venture capital and strategic investors. Notable previous funding rounds include a Series A effort targeting €1 billion, with earlier tranches of $135 million and $85 million secured in recent years.

The pro-forma market capitalization post-combination is anticipated to reach approximately $2.9 billion, with an enterprise value around $2.37 billion. This valuation reflects the significant capital expenditure required for advanced nuclear technology development and deployment. NewHold Investment Corp III's CEO, Kevin Charlton, brings extensive experience in SPAC mergers, having previously led successful combinations for companies like NRC Group, Daseke, and Blue Bird.

The strategic partnerships forged by newcleo further bolster its market position. Collaborations with industrial heavyweights such as Saipem and Fincantieri, as well as a joint venture with JAVYS for plant deployment in Slovakia and a fuel production facility agreement with Oklo Inc. in the USA, demonstrate a clear path towards commercialization. The company has also committed over $70 million to R&D at the ENEA research center, focusing on advanced reactor designs.

This Nasdaq listing represents a pivotal moment for the advanced nuclear sector, signaling increased investor appetite for innovative energy solutions. The successful completion of the business combination, pending shareholder and regulatory approvals, is expected in the second half of 2026. newcleo's journey from a promising scaleup to a publicly traded entity underscores the growing momentum behind next-generation nuclear power as a critical component of the global energy transition.